EUVIMEDOntdek EUVIMED
Crossref

The low hanging fruit of anti‐inflammatory reliever therapy

Richard Beasley iD

Respirology · 2024

DOI: 10.1111/resp.14653 ↗

At a glance

Journal article in Respirology, 2024. Written by Richard Beasley. Institution: Medical Research Institute of New Zealand, Wellington, New Zealand. Major MEDLINE topics: Budesonide, Anti-Asthmatic Agents. Cited 1 times so far (Crossref).

SamenvattingSubjectsBibliografische gegevensCiteRelated studies

Abstract (original language)

Geen abstract beschikbaar.

Subjects

MeSH terms (MEDLINE)

BudesonideAnti-Asthmatic AgentsHumansBronchodilator AgentsAnti-Inflammatory AgentsFormoterol FumarateAdministration, InhalationEthanolaminesAdrenal Cortex HormonesDrug Combinations

Author keywords

anti-inflammatory reliever therapyasthmasevere exacerbations

Substances

BudesonideBronchodilator AgentsAnti-Inflammatory AgentsFormoterol FumarateAnti-Asthmatic AgentsEthanolaminesAdrenal Cortex HormonesDrug Combinations

Authors and institutions

  • Medical Research Institute of New Zealand, Wellington, New Zealand.

ORCID profiles: Richard Beasley

Cite

APA

Beasley, R. (2024). The low hanging fruit of anti‐inflammatory reliever therapy. Respirology. https://doi.org/10.1111/resp.14653

Vancouver

Beasley R. The low hanging fruit of anti‐inflammatory reliever therapy. Respirology. 2024. doi:10.1111/resp.14653

BibTeX
@article{Beasley2024,
  author = {Beasley, Richard},
  title = {The low hanging fruit of anti‐inflammatory reliever therapy},
  journal = {Respirology},
  year = {2024},
  doi = {10.1111/resp.14653}
}
Start for free →